The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the future
Drug Saf
.
2014 Nov;37 Suppl 1(Suppl 1):S1-7.
doi: 10.1007/s40264-014-0181-8.
Authors
Paul B Watkins
1
,
Michael Merz
,
Mark I Avigan
,
Neil Kaplowitz
,
Arie Regev
,
John R Senior
Affiliation
1
The Hamner-University of North Carolina Institute for Drug Safety Sciences, 6 Davis Drive, PO Box 12137, Research Triangle Park, NC, 27709, USA, pwatkins@thehamner.org.
PMID:
25352323
PMCID:
PMC4212148
DOI:
10.1007/s40264-014-0181-8
No abstract available
Publication types
Introductory Journal Article
MeSH terms
Animals
Chemical and Drug Induced Liver Injury / prevention & control*
Drug Design*
Drug Industry / economics
Drug Industry / methods*
Humans
Risk Assessment / methods